Macular

Age related Macular Degeneration or AMD is a disease that affects millions of Americans every year. There are several factors that contribute to this disease, those being: exposure to bright light, diet, hereditary factors and gender. The main ones that can be controlled consist of exposure to bright light and diet. Those that cannot be controlled are hereditary factors and gender. Prevention of macular degeneration consists of reducing the eyes exposure to bright light and the daily diet of the

There are a few ways doctors test for the presence of macular degeneration and other vision loss causing conditions. With a recommended eye exam every two years or so, ophthalmologist and optometrist usually perform the basic “visual acuity test”. This is the test at the beginning at almost every doctor’s visit, and usually starts with a larger print “E”. The dilated eye exam is the test where your health care professional adds drops to your eyes. These drops cause our pupils to dilate, allowing

you will learn how the body is affected by Macular Degeneration (MD). Different signs and symptoms, as well as the etiology of MD, will be discussed. In the following, diagnosis tests and treatments may also be listed in order to help others who would like to know more about MD. Not to mention, you will learn the incidence and progression of MD. Furthermore, information though agencies and associations, as well as new research about MD will be given. Macular Degeneration

Macular Degeneration Condition:      Macular Degeneration is a problem in the part of the eye that controls your sharpest central vision. It is a group of diseases that result in a loss of detailed vision. The brain will not just leave the spot empty, so it learns to fill it in with spotty macular cell damage. People most of the time don't tell their doctors (opthalmologists) about it until it is well in advance.      There are two types of Macular

Kristi Guasis Recent developments in the treatment of age-related macular degeneration Age-related macular degeneration (AMD) is a common cause of irreversible blindness in the elderly. AMD is characterized by the progression from early to intermediate stages of the disease. The two major advanced forms are the geographic atrophy (GA) AMD and neovascular AMD. GA or “dry” AMD is characterized by loss of retinal pigment epithelium (RPE) cells and outer layers of the neurosensory retina as well as

The Dilemma of Macular Degeneration According to Baily and Hall, while visual impairment early in life is associated with inherited congenital disorders, abnormal fetal devepment, and problems associated with premature birth, most eye conditions are associated with aging. They claim that over 70% of the visually impaired population in the United States is over 65. Age related maculopathy, also called macular degeneration, or AMD, impairs the center of vision in older individuals. The macula

Review: Age related macular degeneration (AMD) is the leading cause of blindness in people over the age of 50. Every ten years after the age of 50 the prevalence of this disease increases exponentially. Many different factors contribute to the development of AMD including genetic, environment, and metabolic functions. Aside from smoking, abnormal blood pressure, and an unhealthy diet low in fruits and vegetables, many more studies are concluding that similar inflammatory and oxidative processes

Macular Degeneration in Two Forms Macular Degeneration is a disease of the eye that gradually causes loss of a person’s central vision. Approximately 1.75 million Americans suffer from vision loss associated with the disease (All About Vision 1). The leading cause of blindness in people over the age of 60, Macular Degeneration, exists in two types (National Eye Institute 1). Both the wet and dry versions of the disease have similarities in risk factors, but differ in symptoms and treatments. Although

Age-related macular degeneration (AMD) is a clinical condition in which there is a progressive decrease in central vision. There are two forms of macular degeneration, dry/nonexudative and wet/exudative, and these differ in fundal findings and treatment options. Dry macular degeneration is due to accumulation of drusen between the retinal pigment epithelium and Bruch’s membrane and eventually progresses to geographic atrophy. Geographic atrophy refers to loss of retinal pigment epithelium (RPE)

The research topic I will be introducing is Age-Related Macular Degeneration. This has been classified as a degenerative disorder that distresses the macula in one’s eye. AMD is unfortunately a common illness that individuals over 65 suffer from and that is a central cause vision loss. AMD doesn’t have a set disease pathway, in some individuals it advances slowly so that loss of vision does not arise for a long time. The disease can also advance much quicker and may lead to lack of vision in either